Rheumatic Disease Clinics of North America

Papers
(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Pediatric Rheumatology Comes of Age: Part II79
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases62
Implementation Science in Pediatric Rheumatology: A Path to Health Equity46
Contents37
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis33
Copyright33
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis25
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children22
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis22
Osteoarthritis Treatment Guidelines from Six Professional Societies21
Forthcoming Issues20
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota19
COPA Syndrome from Diagnosis to Treatment19
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy19
Copyright18
Why It Hurts17
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica17
Contributors16
B Cells in Systemic Lupus Erythematosus15
The Short and Long of COVID-1915
Venous Thromboembolism in the Inflammatory Rheumatic Diseases14
Newer Immunosuppressants for Rheumatologic Disease13
Imaging Challenges and Developments in Large-vessel Vasculitis13
Contents13
T Cells in Systemic Lupus Erythematosus13
Vaccinations in Patients with Rheumatic Disease13
Taxonomy of Quality of Care Indicators13
Lessons Learned from the COVID-19 Pandemic in Rheumatology13
Contents12
It Takes Oysters to Generate Pearls12
Primary Cardiac Involvement in Systemic Sclerosis12
De novo Connective Tissue Disorders as Immune-related Adverse Events11
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease11
Pulmonary Hypertension Associated with Connective Tissue Disease10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events10
Expanding the Treatment Team10
Uveitis in Children and Adolescents9
Low Back Pain in Adolescent and Geriatric Populations9
Scleroderma: Best Approaches to Patient Care9
Copyright9
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease8
Rheumatology Pearls for the Primary Care Physician8
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 20198
COVID-19 and Rheumatology8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis8
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases8
Charles L Christian7
Daniel J McCarty, MD: A Giant of Rheumatology7
Cardiac MRI in Rheumatic Disease7
Contributors6
Contributors6
Preventative Care in Scleroderma6
A Guide to Contemporary Clinical Practice Guidelines6
Chronic Nonbacterial Osteomyelitis6
Heart Failure in Rheumatic Disease6
Guideline Development and Implementation in Rheumatic Disease6
Systemic Lupus Erythematosus Classification and Diagnosis6
Contents5
E Carwile LeRoy, MD5
Imaging of Pulmonary Manifestations of Connective Tissue Disease5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis5
Forthcoming Issues5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus5
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy5
Copyright5
The Power of Systems Biology5
Copyright5
Imaging of the Major Salivary Glands in Rheumatic Disease5
Contributors5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus5
Beyond Coronary Artery Disease5
Treatment Guidelines in Gout4
Cardiovascular Health in Pediatric Rheumatologic Diseases4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
The Role of Psychology in Pediatric Rheumatic Diseases4
Genetic Defects in Early-Onset Inflammatory Bowel Disease4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma4
Treatment Guidelines in Pediatric Rheumatic Diseases4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Patient Engagement in Pediatric Rheumatology Research4
CARRA4
Copyright4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”4
Role of Environment in Pediatric Rheumatic Diseases4
0.23292398452759